Loading clinical trials...
Loading clinical trials...
GFREE - A Study for Improved Blood Sugar Levels, Reduced Inflammation and for Increasing Knowledge of the Connection Between Diabetes and COVID-19.
Conditions
Interventions
gluten-free
probiotic
+1 more
Locations
2
Sweden
Sahlgrenska University Hospital
Gothenburg, Sweden
University of Skövde
Skövde, Sweden
Start Date
May 4, 2023
Primary Completion Date
December 1, 2025
Completion Date
December 31, 2030
Last Updated
October 15, 2024
NCT07224321
NCT01399385
NCT07239336
NCT07340320
NCT07536516
NCT06513026
Lead Sponsor
Göteborg University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions